Health5 hours ago
Sanofi and Orano Med Achieve Phase 2 Success in Rare Cancer Treatment
Sanofi and its partner, Orano Med, announced on October 25, 2023, that their alpha-emitting radiopharmaceutical candidate has achieved a significant milestone in its Phase 2 clinical...